NCT01997749

Brief Summary

The purpose of this controlled, randomized intervention is to investigate whether a fat-based (ketogenic) diet given for a week has a positive effect on blood sugar, mortality and function in patients hospitalized with acute stroke compared to the effect of a usual diet. The study hypothesis is that a ketogenic diet and reduced availability of glucose to the brain cells will reduce the volume of neuronal damage in the brain and improve function. The intervention will take place at the neurological units of Glostrup and Bispebjerg Hospital in Denmark.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started May 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 28, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 28, 2013

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

July 18, 2014

Status Verified

July 1, 2014

Enrollment Period

7 months

First QC Date

October 28, 2013

Last Update Submit

July 17, 2014

Conditions

Keywords

stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection

Outcome Measures

Primary Outcomes (3)

  • Change from baseline NIHSS (national institute of health stroke scale) at 90 days

    NIHSS is a common stroke scale used to objectively quantify the impairment caused by a stroke

    Baseline and 90 days

  • Change from baseline fasting blood sugar at 7 days

    Baseline and 7 days

  • Change from baseline p-C-peptide at 7 days

    Baseline and 7 days

Secondary Outcomes (14)

  • Change from baseline p-triglyceride (fasting) at 7 days

    Baseline and 7 days

  • Change from baseline p-LDL at 7 days

    Baseline and 7 days

  • Change from baseline p-CRP at 7 days

    Baseline and 7 days

  • Change from baseline p-beta-hydroxy butyrate at 7 days

    Baseline and 7 days

  • Change from baseline p-phosphate at 7 days

    Baseline and 7 days

  • +9 more secondary outcomes

Study Arms (2)

Ketogenic diet

EXPERIMENTAL

Acute stroke patients will receive a ketogenic diet (Ketocal 4:1 and ketogenic meals) for the first week after inclusion

Dietary Supplement: Ketocal 4:1 (Nutricia)Dietary Supplement: Ketogenic meals

Control diet

ACTIVE COMPARATOR

Acute stroke patients will receive a control diet (the regular diet, enteral or oral, offered at the hospitals) for the first week after inclusion.

Dietary Supplement: Control diet: Regular diet offered at the hospitals

Interventions

Ketocal 4:1 (Nutricia)DIETARY_SUPPLEMENT
Ketogenic diet
Ketogenic mealsDIETARY_SUPPLEMENT
Ketogenic diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with ischemic or hemorrhagic stroke.
  • NIHSS score of at least 5.
  • Both primary and recurrent cases.
  • Patients with expected hospitalization for a minimum of seven days.
  • Adult patients with cognitive ability to give informed consent.
  • Patients with writing and orally accepted participation.

You may not qualify if:

  • Patients with SAH and traumatic hematoma.
  • Patients with pancreatic insufficiency (steatorrhea).
  • Patients unable to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glostrup Hospital

Glostrup Municipality, Copenhagen, 2600, Denmark

Location

MeSH Terms

Conditions

StrokeKetosisIschemiaHyperglycemia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesAcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsGlucose Metabolism Disorders

Study Officials

  • Jens Rikardt Andersen, MD

    University of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.Med.Sci./Ph.D.

Study Record Dates

First Submitted

October 28, 2013

First Posted

November 28, 2013

Study Start

May 1, 2013

Primary Completion

December 1, 2013

Study Completion

February 1, 2014

Last Updated

July 18, 2014

Record last verified: 2014-07

Locations